bevantolol has been researched along with berotek in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arnaud, A; Bruguerolle, B; Philip-Joet, F; Saadjian, A | 1 |
1 trial(s) available for bevantolol and berotek
| Article | Year |
|---|---|
Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Fenoterol; Forced Expiratory Volume; Heart Rate; Humans; Male; Peak Expiratory Flow Rate; Propanolamines; Random Allocation; Respiration; Time Factors | 1986 |
2 other study(ies) available for bevantolol and berotek
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |